-
President-elect Donald Trump has nominated Robert F. Kennedy Jr. as HHS Secretary and Dr. Mehmet Oz for CMS Administrator, raising concerns over their lack of public health experience and ties to anti-vaccine sentiments. The selections could significantly impact U.S. health policy and drug regulation.
-
At the Bloomberg American Health Summit, Michael Bloomberg urged Senate Republicans to oppose Robert F. Kennedy Jr.'s nomination as Health Secretary, citing concerns over vaccine skepticism and public health. Bloomberg emphasized the need for leaders who support vaccination and public health initiatives, especially amid potential health crises like bird flu.
-
President-elect Donald Trump has nominated several controversial figures for key health positions, including Jay Bhattacharya for NIH director and Doug Collins for VA secretary. These nominations face potential Senate opposition, particularly from moderate Republicans concerned about their past statements and qualifications.
-
As President-elect Donald Trump prepares to take office, his controversial health nominees, including Robert F. Kennedy Jr. for HHS and Jay Bhattacharya for NIH, raise alarms among public health experts. Their stances on vaccines and infectious disease management could jeopardize the nation's pandemic preparedness amid rising bird flu concerns.
-
Senate Democrats, led by Chuck Schumer, express willingness to work with Republicans on confirming President-elect Trump's nominees, despite concerns over bypassing traditional FBI vetting. The debate centers on the implications of using private firms for background checks and potential recess appointments.